Research Article
Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome
Table 2
Downregulated serum proteins in YDH syndrome group quantified by iTRAQ-based proteomics and the ratios to the control group.
| Protein ID | Gene name | Protein name | M/C (114/113) | M/C (116/115) | Run 1 | Run 2 | Mean | Run 1 | Run 2 | Mean |
| P02091 | Hbb | Hemoglobin subunit beta-1 | 0.71 | 0.70 | 0.71 | 0.67 | 0.70 | 0.68 | P05545 | Serpina3k | Serine protease inhibitor A3K | 0.66 | 0.64 | 0.65 | 0.65 | 0.70 | 0.68 | Q6IE52 | Mug2 | Murinoglobulin-2 | 0.67 | 0.75 | 0.71 | 0.42 | 0.73 | 0.58 | P15978 | RT1-Aw2 | Class I histocompatibility antigen | 0.73 | 0.61 | 0.67 | 0.58 | 0.60 | 0.59 | P36953 | Afm | Afamin | 0.54 | 0.45 | 0.49 | 0.74 | 0.69 | 0.72 | Q62894 | Ecm1 | Extracellular matrix protein 1 | 0.77 | 0.55 | 0.66 | 0.52 | 0.51 | 0.52 | O88201 | Clec11a | C-type lectin domain family 11 member A | 0.77 | 0.53 | 0.65 | 0.32 | 0.72 | 0.52 | P55314 | C8b | Complement component C8 beta chain | 0.74 | 0.74 | 0.74 | 0.37 | 0.47 | 0.42 | P14630 | Apom | Apolipoprotein M | 0.64 | 0.44 | 0.54 | 0.53 | 0.60 | 0.57 | P35859 | Igfals | Insulin-like growth facto | 0.50 | 0.58 | 0.54 | 0.44 | 0.58 | 0.51 | P14046 | A1i3 | Alpha-1-inhibitor 3 | 0.48 | 0.56 | 0.52 | 0.67 | 0.34 | 0.50 | Q64268 | Serpind1 | Heparin cofactor 2 | 0.74 | 0.70 | 0.72 | 0.24 | 0.31 | 0.27 | Q68FP1 | Gsn | Gelsolin | 0.56 | 0.58 | 0.57 | 0.31 | 0.52 | 0.41 | Q00918 | Ltbp1 | Latent-transforming growth factor | 0.44 | 0.50 | 0.47 | 0.44 | 0.47 | 0.46 | P23680 | Apcs | Serum amyloid P-component | 0.73 | 0.69 | 0.71 | 0.22 | 0.21 | 0.22 | Q8R2H5 | Gpld1 | Phosphatidylinositol | 0.53 | 0.69 | 0.61 | 0.30 | 0.31 | 0.31 | P31211 | Serpina6 | Corticosteroid-binding globulin | 0.54 | 0.50 | 0.52 | 0.36 | 0.36 | 0.36 | Q9QUH3 | Apoa5 | Apolipoprotein A-V | 0.53 | 0.53 | 0.53 | 0.39 | 0.28 | 0.33 | P48199 | Crp | C-reactive protein | 0.72 | 0.72 | 0.72 | 0.10 | 0.19 | 0.14 | O70535 | Lifr | Leukemia inhibitory factor receptor | 0.33 | 0.40 | 0.36 | 0.46 | 0.52 | 0.49 | P55797 | Apoc4 | Apolipoprotein C-IV | 0.33 | 0.53 | 0.43 | 0.43 | 0.41 | 0.42 | P18292 | F2 | Prothrombin | 0.65 | 0.64 | 0.65 | 0.13 | 0.25 | 0.19 | P07092 | Serpine2 | Glia-derived nexin | 0.52 | 0.37 | 0.44 | 0.42 | 0.14 | 0.28 | P19939 | Apoc1 | Apolipoprotein C-I | 0.34 | 0.35 | 0.34 | 0.32 | 0.34 | 0.33 | P07808 | Npy | Pro-neuropeptide Y | 0.63 | 0.29 | 0.46 | 0.13 | 0.24 | 0.19 | O08770 | Gp5 | Platelet glycoprotein V | 0.37 | 0.56 | 0.46 | 0.17 | 0.14 | 0.15 | P55159 | Pon1 | Serum paraoxonase/arylesterase 1 | 0.27 | 0.19 | 0.23 | 0.31 | 0.24 | 0.28 | P06759 | Apoc3 | Apolipoprotein C-III | 0.41 | 0.28 | 0.35 | 0.13 | 0.11 | 0.12 | P04638 | Apoa2 | Apolipoprotein A-II | 0.11 | 0.13 | 0.12 | 0.25 | 0.27 | 0.26 |
|
|
M, model group; C, control group. 114/113 and 116/115, two biological replicates; Run 1 and Run 2, two technical replicates.
|